Pacira BioSciences, Inc. (PCRX) has a consensus analyst rating of Hold, based on 36 analysts covering the stock. Of those, 15 recommend buying, 17 recommend holding, and 4 recommend selling.
The analyst consensus price target for PCRX is $27.00, representing a +13.7% upside from the current price of $23.75. Price targets range from a low of $27.00 to a high of $27.00.
